| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | −23.5× | −1.8× | |
| Price / Book | 7.4× | 2.1× | |
| Price / Sales | — | 4.0× | — |
| Price / Free cash flow | −28.1× | −1.6× | |
| EV / EBITDA | −20.6× | −1.1× | |
| Earnings yield | −4.3% | −14.1% | |
| Free cash flow yield | −3.6% | −9.6% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,276.92 | −2.28% | $1.2T | 59.6× | 77.8% | +21.1% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $263.35 | −1.59% | $633.97B | 24.0× | 32.9% | +39.5% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $283.16 | −0.71% | $500.38B | 119.3× | −129.2% | +23.3% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $422.18 | −0.66% | $378.95B | 31.6× | 12.8% | +16.3% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $143.68 | −2.42% | $354.48B | 19.9× | 34.7% | +68.0% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $154.85 | −0.91% | $279.03B | 20.0× | 30.5% | +19.0% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $169.73 | −1.65% | $263.23B | 26.1× | 21.1% | +3.3% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $669.10 | −1.10% | $247.4B | 37.1× | 12.6% | +21.2% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $440.62 | −1.49% | $238.21B | 31.4× | 89.1% | +48.5% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $156.08 | −0.71% | $193.53B | 22.9× | 37.5% | +26.7% |
